连续5日或以上主力资金净流入个股排名 （文章来源：证券时报网） 证券时报·数据宝统计，截至1月14日收盘，深沪北共90只个股连续5日或5日以上主力资金净流入。税友 股份等连续14日主力资金净流入，排名第一；合锻智能等连续12日主力资金净流入，位列第二。从主力 资金净流入总规模来看，烽火通信主力资金净流入金额最大，连续6天累计净流入24.34亿元，用友网络 紧随其后，5天累计净流入19.08亿元。从主力资金净流入占成交额的比例来看，美年健康占比排名居 首，该股近5日上涨50.65%。（数据宝） | 605168 | 三人行 | 12 | 4.14 | 6.01 | 33.84 | | --- | --- | --- | --- | --- | --- | | 000875 | 吉电股 | 6 | 3.78 | 8.73 | 19.61 | | | 份 | | | | | | 000538 | 云南白 | 8 | 3.77 | 8.60 | -0.21 | | | 药 | | | | | | 603171 | 税友股 | 14 | 3.62 | 4.61 | 76.40 | | | 份 | | | | | | 6 ...

Market Overview - A-shares experienced a collective rise in the morning, followed by a decline in the afternoon, with the Shenzhen Component Index and ChiNext Index closing up by 0.56% and 0.82% respectively, while the Shanghai Composite Index fell by 0.31% [1] - The total market turnover reached 39.868 billion yuan [1] Sector Performance - The healthcare services sector showed strength, with Meiyan Health (002044) hitting the daily limit and achieving a four-day consecutive rise [2] - Under the influence of AI application trends, several stocks including Sanwei Tiandi (301159) and Zhidema (300785) also hit the daily limit, with over ten stocks including Ping An Insurance and Guizhou Moutai seeing significant gains [2] - The financial sector faced adjustments, with banks and insurance stocks declining, including Shanghai Pudong Development Bank and China Life, which fell over 2% [2] Notable Stock Movements - Tianpu Co. (605255), which had two consecutive days of "limit down," rebounded to hit the limit up again, indicating a "quasi-limit up" trend [4][5] - During the closing auction phase, several heavyweight stocks showed large sell orders, with China Merchants Bank having over 6.5 billion yuan in sell orders [4] Commercial Aerospace Sector - The commercial aerospace sector remained active, with stocks like Qifeng Precision and Liujin Technology experiencing significant gains [9] - Recent successful satellite launches, including the Remote Sensing No. 50 satellite and a batch of low-orbit satellites, have contributed to the sector's momentum [13] Earnings Forecasts - Companies with positive earnings forecasts for 2025 are performing well, driven by trends in the AI industry [15] - Lakala (300773) expects a net profit of 1.06 to 1.2 billion yuan for 2025, representing a year-on-year increase of 202% to 242% [17] - Dazhu CNC (301200) anticipates a net profit of 785 to 885 million yuan for 2025, reflecting a growth of 160.64% to 193.84% [18] - Baiwei Storage forecasts a net profit of 850 to 1 billion yuan for 2025, indicating a substantial increase of 427.19% to 520.22% [18]

Market Overview - The market experienced a pullback after an initial rise, with the three major indices dropping sharply in the afternoon. The minimum margin ratio for financing was raised from 80% to 100%, which is expected to help reduce leverage levels and promote long-term market stability [1][3] - The total trading volume exceeded 3.9 trillion yuan, setting a new historical high, with an increase of nearly 300 billion yuan compared to the previous trading day. Oriental Securities anticipates that this active trading pattern will continue until the Spring Festival [1][9] Sector Performance - AI applications showed strong performance, with e-commerce, marketing, and healthcare sectors leading the gains. Stocks such as Meinian Health and Zhidingmai hit the daily limit [1] - The semiconductor industry also saw a rise, with stocks like Longxin Technology and Shenghui Integration hitting the daily limit or increasing by over 10% [1] - The commercial aerospace sector rebounded, with multiple stocks such as Sanwei Communication and Haige Communication hitting the daily limit [1] - The photovoltaic sector experienced another surge, with stocks like Dike Co. and Guosheng Technology hitting the daily limit or increasing by over 10% [1] - Conversely, sectors such as humanoid robots, banking, and insurance saw declines [1] Individual Stock Movement - A total of 2,747 stocks rose, while 2,592 stocks fell, with 131 stocks remaining unchanged. There were 111 stocks that hit the daily limit, and 20 stocks that fell to the limit [1] Financing Margin Adjustment - The financing margin ratio for new contracts has been adjusted to 100% as of January 14, 2026, following approval from the China Securities Regulatory Commission. This adjustment aims to lower leverage levels and protect investors' rights, while existing contracts will remain under previous regulations [3] Automotive Industry Outlook - The China Automotive Industry Association reported that in 2025, automotive production and sales are expected to reach 34.53 million and 34.40 million units, respectively, marking a year-on-year increase of 10.4% and 9.4%. This will be the 17th consecutive year that China maintains its position as the world's largest automotive market [4] - New energy vehicles are projected to exceed 16 million units in sales, with domestic new car sales accounting for over 50% of the market [4] Future Market Predictions - CITIC Securities suggests that the year-end market rally may continue, but short-term technical pullback risks are rising. The market is expected to focus on future industry hotspots, particularly in AI and semiconductors [6][9] - Zhongtai Securities recommends prioritizing small-cap growth and innovation-driven sectors, noting that the spring market rally typically lasts around 30 trading days, with an average gain of about 15% [8] - Oriental Securities believes that the current market conditions are favorable for volume and price, predicting continued active trading until the Spring Festival, with a focus on sectors like AI and brain-computer interfaces [9]

Group 1 - The core viewpoint is that the integration of AI in healthcare and pharmaceuticals is gaining momentum, with significant stock price increases in related companies such as Meinian Health and Zhaoyan New Drug [1] - The Medical Equipment ETF (159873) has seen continuous capital inflow over the past four days, totaling 26.5 million yuan, reaching new highs in both scale and shares since its inception [2] - The Medical Equipment ETF has a high concentration in brain-computer interface technology, accounting for over 17%, with nearly 80% of its components from the Sci-Tech Innovation Board and the Growth Enterprise Market, indicating strong technological attributes [2] Group 2 - The Innovative Drug ETF Tianhong (517380) has experienced net inflows for six consecutive days, with a total of 254 million yuan in the last five days, reflecting strong investor interest [3] - The Innovative Drug ETF spans the Shanghai, Hong Kong, and Shenzhen markets, covering the entire industry chain from preclinical research to commercialization, which helps mitigate investment uncertainties [3] - OpenAI's launch of ChatGPTHealth marks the beginning of an AI-driven healthcare era, enhancing privacy through data isolation and involving over 260 doctors from 60 countries in model optimization [3]

Market Overview - A-shares experienced a collective rebound on January 14, with the Shanghai Composite Index rising over 1% and the ChiNext Index increasing over 2% [1] - The total trading volume in the Shanghai and Shenzhen markets reached 2.22 trillion yuan, a decrease of 215.5 billion yuan compared to the previous trading day [1] - Key sectors showing strong performance included AI applications, medical services, and internet finance, with numerous stocks hitting the daily limit [1][2] Sector Performance - The AI application sector saw significant gains, with over twenty constituent stocks reaching the daily limit, including Liou Co., which achieved six consecutive limit-ups in nine days [1] - The medical services sector also performed well, with companies like Nuo Si Ge and Pu Rui Si seeing increases of over 20%, and Mei Nian Health hitting the limit [1] - The internet finance sector was active, with La Ka La reaching a 20% limit-up and several other stocks rising over 10% [1] - Conversely, the banking sector faced adjustments, with Chongqing Bank and Hangzhou Bank both declining over 1% [1][2] Institutional Insights - CITIC Securities highlighted that AI in healthcare is expected to accelerate the restructuring of the trillion-yuan pharmaceutical market, with a stronger payment capability anticipated by 2026 [3] - Huatai Securities noted that the introduction of new REITs policies by the end of 2025 could lead to a significant development phase for C-REITs, enhancing asset liquidity and value reassessment for commercial real estate [3] - Galaxy Securities emphasized the ongoing commercialization of AI applications, particularly in generative search and content interaction, suggesting a focus on core internet assets and AI-enabled applications [4] Trade Data - China's total goods trade import and export value reached 45.47 trillion yuan in 2025, marking a 3.8% year-on-year increase and maintaining growth for nine consecutive years [5] - Exports reached 26.99 trillion yuan, up 6.1%, while imports hit a record high of 18.48 trillion yuan, growing by 0.5% [5] Medical Supply Procurement - The sixth batch of high-value medical consumables procurement results was announced, including 12 types of medical consumables, with 202 companies and 440 products successfully procured [6] Chip Export Regulations - The U.S. government has relaxed export controls on NVIDIA's H200 chips to China, allowing for renewed shipments to Chinese clients, with the U.S. Department of Commerce overseeing the approval process [7]

Market Overview - The three major indices collectively rebounded on January 14, with the Shanghai Composite Index rising by 1.2%, the Shenzhen Component Index by 1.98%, and the ChiNext Index by 2.24%. Over 4,700 stocks in the market rose, with more than 100 stocks hitting the daily limit. The trading volume in the Shanghai and Shenzhen markets reached 2.22 trillion yuan, a decrease of 215.5 billion yuan compared to the previous trading day [1]. Sector Performance AI Applications - The AI application sector continued to strengthen, with stocks like Zhejiang Wenlian rising for three consecutive days, and Shiji Information hitting the daily limit. Other notable performers included Guangyun Technology and Zhidema, both rising over 10%. This surge follows Google's announcement of partnerships with major retailers and the launch of an open-source AI protocol for e-commerce [2]. Nonferrous Metals - The nonferrous metals sector experienced a rally, particularly in small and precious metals. Xianglu Tungsten Industry hit the daily limit, while Huaxi Nonferrous, Xingye Silver, and Xiamen Tungsten Industry reached historical highs. The tungsten market has seen significant price increases, with tungsten powder prices exceeding 1.1 million yuan per ton [3]. Semiconductor Equipment - Semiconductor equipment stocks saw continued growth, particularly in the cleanroom segment. Stocks like Shenghui Integration and Yashang Integration hit the daily limit and reached historical highs. The demand for equipment is expected to rise due to increased capacity utilization in domestic wafer fabs and the AI-driven storage supercycle [4]. Quantum Technology - The quantum technology sector experienced fluctuations but ultimately rose, with stocks like Demai Chemical hitting the daily limit. The Ministry of Industry and Information Technology has indicated a focus on quantum technology and brain-computer interfaces during the 14th Five-Year Plan [5]. Institutional Insights Market Outlook - According to Everbright Securities, the recent market adjustment is primarily due to profit-taking, but the overall market sentiment remains optimistic. The indices are expected to undergo a period of consolidation, with structural trends likely to continue [6][7]. AI in Healthcare - CITIC Securities reports that AI in healthcare is set to accelerate the restructuring of the trillion-yuan pharmaceutical market. By 2026, the commercialization of AI in healthcare is expected to become more certain, with a focus on AI drug development and medical data circulation [8]. Brain-Computer Interface Technology - Galaxy Securities notes that brain-computer interface technology is transitioning from laboratory research to industrial production, with significant developments expected from companies like Neuralink. The industry is supported by various policies aimed at promoting commercialization and innovation [9]. Space Photovoltaics - Guojin Securities highlights that space photovoltaics will emerge as a leading sector in the new energy market by 2026, driven by its high value and market recognition. The recent cancellation of export tax rebates is expected to create a "window" for companies to adjust before the seasonal downturn [10].

中邮证券发布研报称，2026年初政策支持与海外AI医疗公司高增长表现，共同催化"AI+医疗"产业机 遇。据预测，2030年全球市场规模有望达1553亿美元，中国将快速增长至168亿美元。AI在制药、医疗 影像、辅助诊疗等领域正步入成熟应用，推动产业链价值提升，医疗AI三类证审批加速进一步助力行 业持续扩张。 中邮证券主要观点如下： 政策及板块热点共振，"AI+医疗"有望迎来加速 政策面：2026年1月7日，国家工业和信息化部等八部门联合印发了《"人工智能+制造"专项行动实施意 见》提出要"推动智能装备迭代"，重点提及AI在高端医疗装备、远程医疗等场景应用，相关领域有望显 著受益于政策驱动。 "AI+医疗"市场有望超千亿美元，板块享受估值溢价 市场空间方面，"AI+医疗"行业人工智能解决方案的全球市场规模预计将由2022年的137亿美元增至 2030年的1553亿美元，CAGR为35.5%，中国市场至2030年有望达到168.3亿美元，行业存在爆发式增长 机会。在国内政策导向下，医疗AI三类证审批加速，截至2025年12月5日，累计已有207款人工智能医 疗器械获三类医疗器械注册证，其中，2025年以来新增获批 ...

Market Performance - The Shanghai Composite Index rose by 1.2%, the Shenzhen Component Index increased by 1.98%, the ChiNext Index gained 2.24%, and the Northern Stock 50 surged by 2.96% [1] - The total market turnover reached 22,459 billion yuan, a decrease of 2,224 billion yuan compared to the previous day [1] Sector Performance - The medical services sector showed strong performance, with companies like Norscare, Prasis, and Hongbo Pharmaceutical rising over 20%, and Meinian Health hitting the daily limit [1] - The AI application sector continued to perform well, with stocks such as Sanwei Tiandi, Zhidema, and Zhuoyi Information reaching the daily limit, while several others like Shengguang Group and Xinhua Dou also hit the limit [1] - The internet finance sector was active, with Lakala hitting the daily limit and companies like Yingshisheng and Yinzhijie rising over 10% [1] - The banking sector experienced a pullback, with Chongqing Bank and Hangzhou Bank both declining over 1% [1]

Core Viewpoint - The AI healthcare sector is experiencing significant growth, with both A-shares and Hong Kong stocks showing strong performance, particularly in AI medical ETFs and related stocks [1][2][3] Group 1: A-share Market Performance - The largest medical ETF in the A-share market (512170) surged by 3%, reaching a near three-month high, with active trading exceeding 1 billion CNY within the first hour of trading [1] - Key stocks such as Meiyuan Health and Weining Health saw substantial gains, with Meiyuan Health achieving a four-day consecutive rise and Weining Health spiking by 14% at one point [1] Group 2: Hong Kong Market Performance - The Hong Kong medical sector continues to strengthen, with the Hong Kong Stock Connect medical theme index rising consistently since the beginning of the year, led by Alibaba Health, which increased by nearly 10% [2] - The newly listed Hong Kong Stock Connect medical ETF (159137) has seen significant gains, with a trading volume exceeding 110 million CNY and a peak increase of nearly 3% within three days of its launch [2] Group 3: AI Healthcare Developments - Recent collaborations in the AI healthcare field include a partnership between NVIDIA and Eli Lilly to invest 1 billion USD over five years in an AI drug development lab in Silicon Valley [3] - In China, Tsinghua University's team has developed an AI-driven high-throughput drug virtual screening platform, DrugCLIP, with research results published in the journal Science [3] - The penetration rate of AI healthcare applications is rapidly increasing, with Ant Group's AI assistant, Antifufu, surpassing 30 million monthly active users, and OpenAI's ChatGPT Health reaching over 40 million daily users globally [3] Group 4: Brain-Computer Interface Developments - Elon Musk announced that Neuralink's brain-computer interface products are set to enter mass production by 2026, with nearly automated surgical procedures [3] - Strong Brain Technology, a leading domestic company in the brain-computer interface sector, has submitted an IPO application to the Hong Kong Stock Exchange [3] - The Ministry of Industry and Information Technology in China has indicated a focus on quantum technology and brain-computer interfaces during the 14th Five-Year Plan, emphasizing technological breakthroughs and enterprise cultivation [3]

行业相对指数表现（相对值） 强于大市 |维持 行业基本情况 | | 收盘点位 | 8787.25 | | --- | --- | --- | | 52 | 周最高 | 9323.49 | | 52 | 周最低 | 6790.4 | 2025-01 2025-03 2025-06 2025-08 2025-10 2026-01 -4% 0% 4% 8% 12% 16% 20% 24% 28% 32% 36% 医药生物 沪深300 资料来源：聚源，中邮证券研究所 证券研究报告：医药生物|点评报告 行业投资评级 l AI 在制药、辅助诊断、医疗服务等领域步入成熟阶段 在制药领域，凭借 AI 技术平台强大的数据分析和模型预测能力， 相关公司在分子设计和药物筛选方面能够大幅提升药物的研发效率 和成功率。AI 制药公司通过和大型药企合作共同推动管线进展，涉及 计算机、物理、化学、生物、临床等交叉领域，管线推进越靠后，价 值量显著增高。在影像/手术领域：AI 通过在医疗影像分析方向深度 学习，能够快速识别病灶，实现精准诊断；AI 亦能辅助术前及术中及 时规划，并提供综合解决方案。在辅助诊断领域，主要参与者为数据 驱动型平台 ...